Imunon, Inc. Earnings Per Share, Basic and Diluted
Imunon, Inc. (IMNN) reported Earnings Per Share, Basic and Diluted of -$3.83 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-31
- Imunon, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.06.
- Imunon, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.06.
- Imunon, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.09.
- Imunon, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.24.
- Imunon, Inc. earnings per share, basic and diluted for fiscal 2021 was -$3.83.
- Imunon, Inc. earnings per share, basic and diluted for fiscal 2020 was -$10.08.
- Imunon, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.77.
- Imunon, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.68.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$3.83 10-K · filed 2022-03-31 | |||||||
| 2021-09-30 | -$0.06 10-Q · filed 2021-11-15 | -$0.21 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | -$0.06 10-Q · filed 2021-08-12 | -$0.15 10-Q · filed 2021-08-12 | ||||||
| 2021-03-31 | -$0.09 10-Q · filed 2021-05-14 | |||||||
| 2020-12-31 | -$10.08 10-K · filed 2022-03-31 | -$0.67 10-K · filed 2021-03-19 | ||||||
| 2020-09-30 | -$0.24 10-Q · filed 2021-11-15 | -$0.62 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | -$0.18 10-Q · filed 2021-08-12 | -$0.37 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$0.20 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | -$0.77 10-K · filed 2021-03-19 | |||||||
| 2019-09-30 | -$0.25 10-Q · filed 2020-11-16 | -$0.67 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | -$0.29 10-Q · filed 2020-08-14 | -$0.42 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | -$0.12 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | $0.30 derived: net income ÷ weighted average shares · filed 2020-03-25 | $0.05 derived: net income ÷ weighted average shares · filed 2020-03-25 | -$0.42 derived: net income ÷ weighted average shares · filed 2020-03-25 | -$0.68 10-K · filed 2020-03-25 | ||||
| 2018-09-30 | -$0.26 10-Q · filed 2019-11-14 | -$0.73 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$1.00 10-Q · filed 2019-11-14 | -$1.29 derived: net income ÷ weighted average shares · filed 2019-11-14 | ||||
| 2018-06-30 | -$0.46 10-Q · filed 2019-08-14 | -$0.73 10-Q · filed 2019-08-14 | -$1.03 derived: net income ÷ weighted average shares · filed 2019-08-14 | -$1.58 derived: net income ÷ weighted average shares · filed 2019-08-14 | ||||
| 2018-03-31 | -$0.25 10-Q · filed 2019-05-15 | -$0.56 derived: net income ÷ weighted average shares · filed 2019-05-15 | -$1.09 derived: net income ÷ weighted average shares · filed 2019-05-15 | -$1.68 derived: net income ÷ weighted average shares · filed 2019-05-15 | ||||
| 2017-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$0.90 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$1.55 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$2.72 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | -$0.70 10-Q · filed 2017-11-14 | -$1.41 derived: net income ÷ weighted average shares · filed 2018-11-14 | -$3.04 10-Q · filed 2018-11-14 | -$4.42 derived: net income ÷ weighted average shares · filed 2018-11-14 | ||||
| 2017-06-30 | -$0.70 10-Q · filed 2018-11-14 | -$0.79 10-Q · filed 2017-08-14 | -$1.75 10-Q · filed 2018-08-14 | -$4.14 derived: net income ÷ weighted average shares · filed 2018-11-14 | -$6.59 derived: net income ÷ weighted average shares · filed 2018-11-14 | |||
| 2017-03-31 | -$3.09 10-Q · filed 2018-05-11 | -$0.12 10-Q · filed 2017-05-12 | -$5.71 derived: net income ÷ weighted average shares · filed 2018-05-11 | -$8.94 derived: net income ÷ weighted average shares · filed 2018-05-11 | -$11.60 derived: net income ÷ weighted average shares · filed 2018-05-11 | |||
| 2016-12-31 | -$2.66 derived: net income ÷ weighted average shares · filed 2018-03-27 | -$5.87 derived: net income ÷ weighted average shares · filed 2018-03-27 | -$8.53 derived: net income ÷ weighted average shares · filed 2018-03-27 | -$11.89 10-K · filed 2018-03-27 | -$0.85 10-K · filed 2017-03-24 | |||
| 2016-09-30 | -$3.22 10-Q · filed 2017-11-14 | -$0.23 10-Q · filed 2016-11-10 | -$5.89 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$9.27 10-Q · filed 2017-11-14 | -$0.66 10-Q · filed 2016-11-10 | -$1.76 derived: net income ÷ weighted average shares · filed 2017-11-14 | ||
| 2016-06-30 | -$2.63 10-Q · filed 2017-08-14 | -$0.19 10-Q · filed 2016-08-15 | -$6.04 10-Q · filed 2017-08-14 | -$0.43 10-Q · filed 2016-08-15 | -$0.98 derived: net income ÷ weighted average shares · filed 2017-08-14 | -$1.12 derived: net income ÷ weighted average shares · filed 2017-08-14 | ||
| 2016-03-31 | -$0.24 10-Q · filed 2017-05-12 | -$0.48 derived: net income ÷ weighted average shares · filed 2017-05-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2017-05-12 | -$0.93 derived: net income ÷ weighted average shares · filed 2017-05-12 | ||||
| 2015-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2017-03-24 | -$0.42 derived: net income ÷ weighted average shares · filed 2017-03-24 | -$0.69 derived: net income ÷ weighted average shares · filed 2017-03-24 | -$1.03 10-K · filed 2017-03-24 | ||||
| 2015-09-30 | -$0.19 10-Q · filed 2016-11-10 | -$0.45 derived: net income ÷ weighted average shares · filed 2016-11-10 | -$0.79 10-Q · filed 2016-11-10 | -$1.08 derived: net income ÷ weighted average shares · filed 2016-11-10 | ||||
| 2015-06-30 | -$0.27 10-Q · filed 2016-08-15 | -$0.62 10-Q · filed 2016-08-15 | -$0.90 derived: net income ÷ weighted average shares · filed 2016-08-15 | -$1.28 derived: net income ÷ weighted average shares · filed 2016-08-15 | ||||
| 2015-03-31 | -$0.35 10-Q · filed 2016-05-16 | -$0.62 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$1.01 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$1.39 derived: net income ÷ weighted average shares · filed 2016-05-16 | ||||
| 2014-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.66 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.04 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.38 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | -$0.40 10-Q · filed 2015-11-05 | -$0.35 10-Q · filed 2014-11-10 | -$0.78 derived: net income ÷ weighted average shares · filed 2015-11-05 | -$1.12 10-Q · filed 2015-11-05 | -$1.06 10-Q · filed 2014-11-10 | -$1.31 derived: net income ÷ weighted average shares · filed 2016-03-30 | ||
| 2014-06-30 | -$0.38 10-Q · filed 2015-08-10 | -$0.71 10-Q · filed 2015-08-10 | -$0.91 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.21 derived: net income ÷ weighted average shares · filed 2016-03-30 | ||||
| 2014-03-31 | -$0.33 10-Q · filed 2015-05-11 | -$0.53 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.83 derived: net income ÷ weighted average shares · filed 2016-03-30 | |||||
| 2013-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.49 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.95 10-K · filed 2016-03-30 | |||||
| 2013-09-30 | -$0.30 10-Q · filed 2014-11-10 | -$0.76 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | $0.03 10-Q · filed 2014-08-07 | -$0.45 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | -$0.55 10-Q · filed 2014-05-08 | -$0.12 10-Q · filed 2013-05-09 | -$1.48 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$2.28 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$1.74 derived: net income ÷ weighted average shares · filed 2015-03-12 | |||
| 2012-12-31 | -$0.96 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$1.77 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$1.24 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$3.44 10-K · filed 2015-03-12 | -$0.76 10-K · filed 2013-03-18 | |||
| 2012-09-30 | -$0.80 10-Q · filed 2013-11-12 | -$0.18 10-Q · filed 2012-11-09 | -$0.60 derived: net income ÷ weighted average shares · filed 2013-11-12 | -$2.47 10-Q · filed 2013-11-12 | -$0.55 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | -$0.18 10-Q · filed 2012-08-14 | -$0.37 10-Q · filed 2012-08-14 | ||||||
| 2012-03-31 | -$0.19 10-Q · filed 2013-05-09 | |||||||
| 2011-12-31 | -$5.00 10-K · filed 2014-03-13 | -$1.11 10-K · filed 2012-03-15 | ||||||
| 2011-09-30 | -$0.25 10-Q · filed 2012-11-09 | -$0.93 10-Q · filed 2012-11-09 | ||||||
| 2011-06-30 | -$0.42 10-Q · filed 2012-08-14 | -$0.72 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$0.28 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | -$1.52 10-K · filed 2013-03-18 | |||||||
| 2010-09-30 | -$0.38 10-Q · filed 2011-11-10 | -$1.10 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | -$0.22 10-Q · filed 2011-08-09 | -$0.72 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |